Cheniere Energy Partners (CQP:ASE) and NovaBay Pharmaceuticals (NBY:ASE) Are Fully Valued

Stockcalc – Free Trial

Have a free look inside the StockCalc website at www.stockcalc.com



I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available for free at www.stockcalc.com/TopPicks.aspx.

Fully Valued Stocks on AMEX

Today we are looking at companies that are considered fully valued based on the Analyst data in the StockCalc database.

In this table we can see the close price and target price for these companies along with the number of analysts covering the stock. We also have included the fiscal year for the target price as sometimes these analyst targets are not for the current or even the next fiscal year.

There can be a number of reasons why a company would be on this list. What is particularly interesting are companies with a large analyst following that make this list. We need to dig deeper into these companies to understand why the difference in price versus target.

Today’s Data on AMEX

Today’s data is for companies listed on the American Stock Exchange.

Symbol Name Target Year Close Price Target Price Mean Currency Target Price # of Estimates
CQP Cheniere Energy Partners LP 2019 42.180000 39.0000 USD 3
NBY NovaBay Pharmaceuticals Inc 2019 1.690000 1.3750 USD 2

Let’s look at a few companies…

Lets look at a couple of the companies on this list to get a better understanding of them.

CQP:ASE Cheniere Energy Partners

http://www.cheniereenergypartners.com
Cheniere Energy Partners has 1372 employees and is headquartered in United States.
Cheniere Energy Partners LP engages in the liquified natural gas export business. The firm operates through its Sabine Pass liquefaction/terminal/pipeline facilities in Louisiana.

NBY:ASE NovaBay Pharmaceuticals

https://www.novabay.com
NovaBay Pharmaceuticals has 33 employees and is headquartered in United States.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company engaged in commercializing and developing non-antibiotic anti-infective products to address the unmet therapeutic needs of the eye care market. Its product categories include NEUTROX and CELLERX.

Free Valuation

Run a valuation on any of the companies listed above at www.stockcalc.com/valureport.aspx or subscribe at our Stockcalc Facebook Page to receive this list each day Stockcalc Reports.

The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.